Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Barber, Melissa N ^a   Risis, Steve ^a   Yang, Christine ^a   Meikle, Peter J ^a   Staples, Margaret ^b   Febbraio, Mark A ^a   Bruce, Clinton R ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; GLUCOSE; INSULIN; LIPIDOME; LYSOPHOSPHATIDYLCHOLINE; METFORMIN; ORAL ANTIDIABETIC AGENT; SPHINGOLIPID; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID DIET; LIPIDOMICS; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ADIPOSITY; ADULT; ANIMALS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY FATS; HUMANS; INSULIN RESISTANCE; LIVER; LYSOPHOSPHATIDYLCHOLINES; MALE; MICE; MUSCLE, SKELETAL; OBESITY; TIME FACTORS;

MUS; RODENTIA;

EID: 84864365428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041456     Document Type: Article

References (29)

1. Boden G, Shulman GI, (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32: 14-23.
2. Bernstein RM, Davis BM, Olefsky JM, Reaven GM, (1978) Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia. Diabetologia 14: 249-253.
3. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD, (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024.
4. Graessler J, Schwudke D, Schwarz PE, Herzog R, Shevchenko A, et al. (2009) Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS One 15: e6261.
5. Schwab U, Seppänen-Laakso T, Yetukuri L, Agren J, Kolehmainen M, et al. (2008) Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism- the GENOBIN study. PLoS One 3: e2630.
6. Pietiläinen KH, Sysi-Aho M, Rissanen A, Seppänen-Laakso T, Yki-Järvinen H, et al. (2007) Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects- a monozygotic twin study. PLoS One 2: e218.
7. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, et al. (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121: 1402-1411.
8. Karelis AD, (2008) Metabolically healthy but obese individuals. Lancet 372: 1281-1283.
9. Sims EAH, (2001) Are there persons who are obese, but metabolically healthy? Metab Clin Exp 50: 1499-1504.
10. Barbarroja N, López-Pedrera R, Mayas MD, García-Fuentes E, Garrido-Sánchez L, et al. (2010) The obese healthy paradox: is inflammation the answer? Biochem J 430: 141-149.
11. Han MS, Lim YM, Quan W, Kim JR, Chung KW, et al. (2011) Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res. 52: 1234-46.
12. Yea K, Kim J, Yoon JH, Kwon T, Kim JH, et al. (2009) Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes. J Biol Chem 284: 33833-33840.
13. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J, (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55: 2579-2587.
14. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, et al. (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58: 337-343.
15. Xu Y, (2002) Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 1582: 81-88.
16. Xu Y, Fang XJ, Casey G, Mills GB, (1995) Lysophospholipids activate ovarian and breast cancer cells. Biochem J 309: 933-940.
17. Xing F, Liu J, Mo Y, Liu Z, Qin Q, et al. (2009) Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway. J Cell Mol Med 13: 1136-1148.
18. Wang L, Radu CG, Yang LV, Bentolila LA, Riedinger M, et al. (2005) Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A. Mol Biol Cell 16: 2234-2247.
19. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
20. Rabini RA, Galassi R, Fumelli P, Dousset N, Solera ML, et al. (1994) Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes 43: 915-919.
21. Zhao X, Fritsche J, Wang J, Chen J, Rittig K, et al. (2010) Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics 6: 362-374.
22. Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ, (2012) Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology Jan 30 doi:10.1002/hep.25630. [Epub ahead of print].
23. Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA, (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest 119: 531-539.
24. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, et al. (2008) Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134: 933-944.
25. Kus V, Flachs P, Kuda O, Bardova K, Janovska P, et al. (2011) Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet. PLoS One. 2011 6(11): e27126.
26. Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, et al. (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31(11): 2723-32.
27. Smyth I, Hacking DF, Hilton AA, Mukhamedova N, Meikle PJ, et al. (2008) A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis. PLoS Genet 4: e1000192.
28. Meikle PJ, Duplock S, Blacklock D, Whitfield PD, Macintosh G, et al. (2008) Effect of lysosomal storage on bis(monoacylglycero)phosphate. Biochem J 411: 71-78.
29. Matthews VB, Allen TL, Risis S, Chan MH, Henstridge DC, et al. (2010) Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 53: 2431-2441.